gimli
LALPATHLAB stock analysis context
DR. LAL PATH LABS. Stock Context for AI Screening
DR. LAL PATH LABS LTD. is a mid-cap stock in Healthcare. This page summarizes key screening signals for DR. LAL PATH LABS., including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about LALPATHLABPrice
₹1,630.10
1M return
+11.72%
3M return
+16.24%
Market cap
₹27,219.05 cr
PE
72.06
ROE
+18.46%
RSI
59.07
Turnover
₹31.64 cr
Why it can matter in screens
- Momentum: LALPATHLAB is above 50DMA, above 200DMA; RSI is 59.07.
- Returns: 1M +11.72%, 3M +16.24%, 6M +3.76%.
- Liquidity: latest turnover is ₹31.64 cr.
- Valuation: PE 72.06, PB n/a, ROE +18.46%, ROCE +21.16%.
- Growth: 3Y sales CAGR +5.64%, 3Y profit CAGR +12.21%.
Try these prompts
- Analyze DR. LAL PATH LABS. with valuation, momentum and industry peers
- Compare LALPATHLAB with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare LALPATHLAB with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.